Perceptronix Medical : Early Detection Brings Hope

May 16, 2008 - "Early detection of any cancer is always the best hope for successful treatment and a positive outcome, but early detection for lung cancer has never been more important than now," says Bojana Turic, MD, president and CEO of Perceptonix Medical Inc., Vancouver, "when on average 388 Canadians will die of lung cancer every week."

Current international studies show that even smokers who have kicked the habit are still at risk of developing lung cancer since researchers believe that the lung tissue damaged by smoking may never repair to normal status and, therefore, former smokers continue to be at risk throughout their lifetime. The risk decreases the longer one has stopped smoking... [PDF] Perceptonix Medical's Press Release -

Perceptronix, Launch of LungSign(TM)

Sept. 10, 2007 - Perceptronix Announces Launch of LungSign(TM)
...LungSign^TM is a safe, painless and convenient test to assess a patient's risk of lung cancer based on an innovative marker in sputum that is highly correlated with the presence of lung malignancy - even in early stage, presymptomatic disease. As such, LungSign^TM is the first test to market that provides both an independent result to help with the early detection of lung cancer and a useful complement to current radiological diagnostic methods. LungSign^TM may benefit high-risk patients of both sexes, in particular: smokers, former smokers, and individuals exposed to industrial and environmental carcinogens. LungSign^TM is requested and interpreted under the care of a physician... Perceptronix's Press Release [PDF] -